Rod, Cone Function Down for Children Born Extremely Preterm

Share this content:
Rod, Cone Function Down for Children Born Extremely Preterm
Rod, Cone Function Down for Children Born Extremely Preterm

FRIDAY, July 7, 2017 (HealthDay News) -- Children born extremely preterm have reduced rod and cone function compared with children born at term, according to a study published online June 29 in JAMA Ophthalmology.

Anna E.C. Molnar, M.D., Ph.D., from Uppsala University in Sweden, and colleagues compared retinal function in 6.5-year-old children born extremely preterm (52 children) and children born at term (45 children). Retinal function was assessed using full-field electroretinographic (ffERG) recordings.

The researchers found that, compared with the group born at term, the preterm group had significantly lower amplitudes of the combined rod and cone responses (a-wave of the dark-adapted electroretinographic [ERG] protocol of 3.0 and 12.0 candelas [cd]/s/m²: mean differences, −48.9 and −55.7 µV, respectively) and of the isolated cone response (30-Hz Flicker ERG: mean difference, −12.1 µV). The preterm group also had longer implicit time of the combined rod and cone responses (a-wave of the dark-adapted ERG protocol of 12.0 cd/s/m²: mean difference, 1.2 ms) and isolated cone responses (30-Hz flicker ERG: mean difference, 1.2 ms), compared with the group born at term. In the preterm group there was no correlation between ffERG recordings and gestational age or retinopathy of prematurity.

"There was no association with retinopathy of prematurity in the preterm group, which suggests that being born extremely preterm may be one of the main reasons for a general retinal dysfunction," the authors write.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »